Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9291 |
High Similarity |
NPD3027 |
Phase 3 |
0.8931 |
High Similarity |
NPD1613 |
Approved |
0.8931 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8692 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8626 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8385 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8308 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8271 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8074 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8062 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8016 |
Intermediate Similarity |
NPD7843 |
Approved |
0.8 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7969 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7959 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7956 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7953 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7937 |
Intermediate Similarity |
NPD228 |
Approved |
0.7905 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD37 |
Approved |
0.7852 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7852 |
Intermediate Similarity |
NPD4678 |
Approved |
0.784 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7826 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.782 |
Intermediate Similarity |
NPD1091 |
Approved |
0.782 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7815 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7785 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7763 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7762 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7737 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7736 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7736 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7727 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7712 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7704 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7704 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7676 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7671 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7664 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7628 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7626 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD290 |
Approved |
0.761 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7594 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7593 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7589 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7568 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7554 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7534 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7534 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7534 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7534 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7534 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7531 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD291 |
Approved |
0.75 |
Intermediate Similarity |
NPD5588 |
Approved |
0.75 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7465 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7453 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.745 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7444 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7432 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7426 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7424 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7402 |
Intermediate Similarity |
NPD968 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7378 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7364 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7364 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7355 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7355 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7315 |
Intermediate Similarity |
NPD6190 |
Approved |
0.731 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7297 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7292 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7286 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.728 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7279 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7279 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7248 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD52 |
Approved |
0.7237 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7233 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7222 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7203 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7134 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD3179 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD3180 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7095 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7089 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7071 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7071 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7068 |
Intermediate Similarity |
NPD821 |
Approved |
0.7068 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7066 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7034
|
Intermediate Similarity |
NPD2674 |
Phase 3 |